Company / Goodwill
Travere Therapeutics, Inc. Goodwill History
FY2016-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Goodwill
$800.0K
FY2024
5-year range
$800.0K / $900.0K
FY2020-FY2024
Trend
+0.0%
vs FY2023
Sector context
#73 of 74
Health Care
What the data says
Among 74 Health Care companies, Travere Therapeutics, Inc. is in the bottom 1% for goodwill.
Based on SEC 10-K filings.
$800,000 in FY2024 with a 5-year CAGR of -3.1%.
Remained stable around $800,000 over the past 2 years.
Health Care sector context is included.
Goodwill over time
Growth rates
- 3-Year CAGR
- -3.9%
- 5-Year CAGR
- -3.1%
- 10-Year CAGR
- -
Sector benchmark
Bottom 1% in Health CareTop 99% of 74This company $800.0K Sector average $4.0B
▼
-100.0% below sector average
Key checks
Key Insights
- 5-year CAGR of -3.1%, indicating a declining trend.
- In FY2024, goodwill increased 0.0% year-over-year.
- Ranks #73 out of 74 companies in the Health Care sector.
- Peak goodwill was recorded in FY2020.
Company context
Key Data Points
- Altman Z-Score -1.15 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | GoodwillValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | $800.0K | +0.0% |
| FY2023 | $800.0K | +0.0% |
| FY2022 | $800.0K | -11.1% |
| FY2021 | $900.0K | -3.8% |
| FY2020 | $936.0K | +0.0% |
| FY2019 | $936.0K | +0.0% |
| FY2018 | $936.0K | +0.0% |
| FY2017 | $936.0K | +0.0% |
| FY2016 | $936.0K | +0.0% |
As of FY2024 · SEC 10-K · Updated Jun 30, 2026